A Prospective Evaluation of the Analytical Performance of GENECUBE^® HQ SARS-CoV-2 and GENECUBE^® FLU A/B.

ABSTRACT:

Background

Molecular tests are the mainstay of detecting severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). However, their accessibility can be limited by the long examination time and inability to evaluate multiple samples at once.

Objective

This study evaluated the analytical performance of the newly developed rapid molecular assays GENECUBE^® HQ SARS-CoV-2 and GENECUBE^® FLU A/B.

Method

This prospective study was conducted between 14 December 2020 and 9 January 2021 at a polymerase chain reaction (PCR) center. Samples were collected from the nasopharynx with flocked swabs. Molecular tests were performed with the GENECUBE^® system and reference reverse transcription (RT)-PCR, and the results of the two assays were compared.

SUBMITTER: Kiyasu Y 

PROVIDER: S-EPMC8129955 | biostudies-literature | 2021 Jul

REPOSITORIES: biostudies-literature